JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 2 No. 4, April 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Transdermal Nicotine Patches With Low-Intensity Support to Aid Smoking Cessation in Outpatients in a General Hospital

A Placebo-Controlled Trial

Jonathan Foulds, MAppSci; John Stapleton, MSc; Mary Hayward; Michael A. H. Russell, FRCP; Colin Feyerabend, PhD; Tracey Fleming; John Costello, MD, FRCP

Arch Fam Med. 1993;2(4):417-423.


Abstract

Objective
To assess whether transdermal nicotine patches combined with low-intensity support can help outpatients in a general hospital stop smoking.

Design
Randomized, double-blind, placebo-controlled trial with 12 weeks of follow-up.

Setting
Department of Thoracic Medicine in an innercity public general hospital, London, England.

Subjects
Two hundred forty-eight outpatients in a general hospital, who smoked at least 10 cigarettes per day (the majority were being treated for smoking-related diseases), referred by clinicians at the hospital.

Intervention
Brief advice to stop smoking and daily application of transdermal nicotine patches (delivering 15 mg over 16 hours) or placebo, with follow-up appointments at 1, 3, 6, and 12 weeks, with a doubling of the dosage for continuing smokers at week 1.

Main Outcome Measure
Sustained abstinence from tobacco from week 3 to week 12 validated with measurement of expired-air carbon monoxide concentration at weeks 3, 6, and 12.

Results
Twenty-nine (23.4%) of 124 subjects assigned to the nicotine group were validated as having abstained from smoking at both weeks 3 and 6, compared with 16 (12.9%) of 124 subjects receiving placebo (P=.008). At week 12, 22 (17.7%) of the subjects in the nicotine group were validated as having abstained at all three points as were 15 (12.1%) of the subjects in the placebo group (P=.058).

Conclusion
Transdermal nicotine patches combined with low-intensity support are effective in helping outpatients in a general hospital stop smoking but do not prevent relapse after 6 weeks.



Author Affiliations

From the Health Behaviour Unit, Institute of Psychiatry, National Addiction Centre, London, England (Messrs Foulds and Stapleton, Ms Hayward, and Dr Russell); Poisons Unit, New Cross Hospital, London (Dr Feyerabend); and the Department of Thoracic Medicine, Kings College Hospital, London (Ms Fleming and Dr Costello).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Illicit drug use as a predictor of smoking cessation treatment outcome
Stapleton et al.
Nicotine Tob Res 2009;11:685-689.
ABSTRACT | FULL TEXT  

Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: Floating prolonged abstinence
Aveyard et al.
Nicotine Tob Res 2009;11:475-480.
ABSTRACT | FULL TEXT  

Combination treatment with varenicline and nicotine replacement therapy
Ebbert et al.
Nicotine Tob Res 2009;11:572-576.
ABSTRACT | FULL TEXT  

Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation.
Oncken et al.
Arch Intern Med 2006;166:1571-1577.
ABSTRACT | FULL TEXT  

Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients
Molyneux et al.
Thorax 2003;58:484-488.
ABSTRACT | FULL TEXT  

Effectiveness of Over-the-Counter Nicotine Replacement Therapy
Franzon et al.
JAMA 2002;288:3108-3110.
FULL TEXT  

Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support
Hand et al.
Thorax 2002;57:715-718.
ABSTRACT | FULL TEXT  

Can anti-smoking television advertising affect smoking behaviour? Controlled trial of the Health Education Authority for England's anti-smoking TV campaign
McVey and Stapleton
Tobacco Control 2000;9:273-282.
ABSTRACT | FULL TEXT  

Efficacy and Safety of an Over-the-counter Transdermal Nicotine Patch as an Aid for Smoking Cessation
Davidson et al.
Arch Fam Med 1998;7:569-574.
ABSTRACT | FULL TEXT  

Smoking Cessation in Hospitalized Patients: Results of a Randomized Trial
Miller et al.
Arch Intern Med 1997;157:409-415.
ABSTRACT  

Use and Effectiveness of Transdermal Nicotine in Primary Care Settings
Cummings et al.
Arch Fam Med 1994;3:682-689.
ABSTRACT  




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.